Regulation of T cell function by the ubiquitin-specific protease USP9X via modulating the Carma1-Bcl10-Malt1 complex

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 23, 2013, Pages 9433-9438

  Park, Yoon ^a   Jin, Hyung Seung ^a   Liu, Yun Cai ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Posttranslational modification; Signal transduction

Indexed keywords

PROTEIN BCL 10; PROTEINASE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; USP9X PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RELEASE; GENE SILENCING; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

POSTTRANSLATIONAL MODIFICATION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOPTIVE TRANSFER; ANIMALS; CARD SIGNALING ADAPTOR PROTEINS; CASPASES; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; ENDOPEPTIDASES; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MULTIPROTEIN COMPLEXES; NEOPLASM PROTEINS; NF-KAPPA B; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION;

MUS;

EID: 84878710765     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1221925110     Document Type: Article

References (27)

1. Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67:425-479.
2. Kerscher O, Felberbaum R, Hochstrasser M (2006) Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol 22:159-180.
3. Nijman SM, et al. (2005) A genomic and functional inventory of deubiquitinating enzymes. Cell 123(5):773-786.
4. Komander D, Clague MJ, Urbé S (2009) Breaking the chains: Structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 10(8):550-563.
5. Wertz IE, et al. (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430(7000):694-699.
6. Brummelkamp TR, Nijman SM, Dirac AM, Bernards R (2003) Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424(6950):797-801.
7. Trompouki E, et al. (2003) CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424(6950):793-796.
8. Düwel M, et al. (2009) A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains. J Immunol 182(12):7718-7728.
9. Reiley WW, et al. (2007) Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses. J Exp Med 204(6):1475-1485.
10. Schulze-Luehrmann J, Ghosh S (2006) Antigen-receptor signaling to nuclear factor kappa B. Immunity 25(5):701-715.
11. Lee KY, D'Acquisto F, Hayden MS, Shim JH, Ghosh S (2005) PDK1 nucleates T cell receptor- induced signaling complex for NF-kappaB activation. Science 308(5718):114-118.
12. Sun L, Deng L, Ea CK, Xia ZP, Chen ZJ (2004) The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol Cell 14(3):289-301.
13. Wu CJ, Ashwell JD (2008) NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-kappaB activation. Proc Natl Acad Sci USA 105(8):3023-3028.
14. Oeckinghaus A, et al. (2007) Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation. EMBO J 26(22):4634-4645.
15. Langel FD, et al. (2008) Multiple protein domains mediate interaction between Bcl10 and MALT1. J Biol Chem 283(47):32419-32431.
16. Lucas PC, et al. (2001) Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. J Biol Chem 276(22):19012-19019.
17. Gaide O, et al. (2002) CARMA1 is a critical lipid raft-associated regulator of TCRinduced NF-kappa B activation. Nat Immunol 3(9):836-843.
18. Uren AG, et al. (2000) Identification of paracaspases and metacaspases: Two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell 6(4):961-967.
19. Wood SA, et al. (1997) Cloning and expression analysis of a novel mouse gene with sequence similarity to the Drosophila fat facets gene. Mech Dev 63(1):29-38.
20. Schwickart M, et al. (2010) Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 463(7277):103-107.
21. Pérez-Mancera PA, et al.; Australian Pancreatic Cancer Genome Initiative (2012) The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature 486(7402): 266-270.
22. Dupont S, et al. (2009) FAM/USP9X, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination. Cell 136(1):123-135.
23. Thome M, Charton JE, Pelzer C, Hailfinger S (2010) Antigen receptor signaling to NFkappaB via CARMA1, BCL10, and MALT1. Cold Spring Harb Perspect Biol 2(9):a003004.
24. Al-Hakim AK, et al. (2008) Control of AMPK-related kinases by USP9X and atypical Lys (29)/Lys(33)-linked polyubiquitin chains. Biochem J 411(2):249-260.
25. Paul S, Kashyap AK, JiaW, HeYW, Schaefer BC (2012) Selective autophagy of the adaptor protein Bcl10 modulates T cell receptor activation of NF-κB. Immunity 36(6):947-958.
26. Scharschmidt E, Wegener E, Heissmeyer V, Rao A, Krappmann D (2004) Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling. Mol Cell Biol 24(9):3860-3873.
27. Lobry C, Lopez T, Israël A, Weil R (2007) Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10. Proc Natl Acad Sci USA 104(3):908-913.